N-杂环异海松酰基磺酰胺的制备及其抗肿瘤活性
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

TQ351

基金项目:


Synthesis and Antitumor Activity of Isopimaric Hetero-cyclic Sulfonamides Derivatives
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    为了寻求以天然资源为原料的新型抗肿瘤药物,以天然资源异海松酸为原料,设计并合成了6个未见报道的异海松酰基杂环类磺酰胺(5a~5f),并对其结构进行了表征。生物活性测试结果表明,部分化合物对四种人体肿瘤细胞具有良好的抑制活性,在100 μmol/L时异海松酰基-2-氯-5-吡啶磺酰胺(5d)、异海松酰基-3-溴-2-氯吡啶-5-磺酰胺(5e)对人体宫颈癌(Hela)、乳腺癌(MDA-MB-231)、前列腺癌(PC-3)和肝癌(Hep G-2)这四种人体肿瘤细胞都具有良好的抑制活性,对上述人体肿瘤细胞的增值抑制率均大于95%和90%;异海松酰基-3-氯喹啉磺酰胺(5c)对上述四种人体肿瘤细胞的增值具有较好的抑制活性。化合物5d和5e对四种人体肿瘤细胞增值抑制的IC50值均低于临床上应用较广的抗癌剂5-氟尿嘧啶(5-FU),其抑制活性优于阳性对照,有良好的临床应用前景。

    Abstract:

    In order to find new anti-tumor drugs from natural resources, six of new isopimaric thiophene sulfonamides derivatives (5a~5f) were designed and synthesized. And the structure of the compounds was confirmed. In addition, the cell proliferation inhibition assay (MTT method) was used to study the in vitro inhibitory activity of 5a~5f on four human tumor cells. The results showed that some compounds had good inhibitory activities against four kinds of human tumor cells; at the concentration of 100 μg?mL-1, isopimaric acid acyl- 2-chloropyridine-5-sulfonamide(5d) and isopimaric acid acyl- 3-bromo-2-chloropyridine-5-sulfonamide(5e) exhibited favorable ntitumor activities against cervical cancer (Hela), breast cancer cells (MDA-MB-231), prostate cancer (PC-3) and hepatocarcinoma cells (HepG-2) respectively, which was all over 95% and 90%; Isopimaric acid acyl- 3-chloroquinoline-sulfonamide(5c) has a good inhibitory activity on the above four human tumor cells. The IC50 values of compounds 5d and 5e were lower than those of 5-fluorouracil (5-FU), which was widely used in clinic. It indicated that compounds 5d and 5e had good clinical application prospects.

    参考文献
    相似文献
    引证文献
引用本文

卢言菊,赵振东,陈玉湘,毕良武,王婧,徐士超. N-杂环异海松酰基磺酰胺的制备及其抗肿瘤活性[J].精细化工,2021,38(3):

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2020-08-18
  • 最后修改日期:2020-10-14
  • 录用日期:2020-10-14
  • 在线发布日期: 2021-02-02
  • 出版日期:
文章二维码